文献速递关节外科

机器人辅助单髁膝关节置换术的系统综述:应报告假体设计与类型

A systematic review of robotic-assisted unicompartmental knee arthroplasty: prosthesis design and type should be reported.
PubMed 文献 · Bone Joint J · 2019-01-01

该系统综述检索了PubMed和Medline,纳入38项研究,评估机器人辅助单髁膝关节置换术的假体定位、活动度、功能和生存率。六年的汇总生存率为96%,但嵌入式(全聚乙烯)胫骨假体生存率为89%,而覆压式(金属背衬)假体为97%(OR 3.66,95%CI 20.7至6.46,p<0.001)。作者认为机器人辅助假体定位比手工更准确、可重复性更高,可能提供更好的功能结果,但能否转化为中长期假体生存改善尚待观察。

要点

  • 六年汇总生存率为96%,嵌入式胫骨假体生存率89%,覆压式假体97%(OR 3.66,p<0.001)。
  • Mako机器人使用最多(32项研究,84%),Restoris MCK为最常用假体。
  • 9项研究(24%)未报告所用假体,作者认为评估生存率时假体选择至关重要。

核心结论

  • 文献中报告机器人辅助单髁膝关节置换术时对假体选择的描述很少,而这对评估生存率至关重要。
  • 机器人辅助单髁膝关节置换术的假体定位比手工更准确、可重复性更高,可能提供更好的功能结果,但能否转化为中长期假体生存改善尚待观察。

研究设计与样本

  • 按照PRISMA声明于2018年10月检索PubMed和Medline的系统综述。
  • 检索词包括「robotic」、「knee」和「surgery」。
  • 纳入标准为任何描述机器人辅助单髁膝关节置换术并报告假体定位、活动度、功能和生存率的临床、尸体或干骨研究。
  • 初始识别528篇文章,全文筛选后纳入38项满足纳入标准的研究。

主要发现

  • 20项研究报告假体定位,18项报告功能结果,16项报告生存率,6项报告活动度。
  • Mako(Stryker,Mahwah,New Jersey)机器人在32项研究(84%)中使用,BlueBelt Navio(Blue Belt Technologies,Plymouth,Minnesota)在3项(8%)中使用,Sculptor RGA(Stanmore Implants,Borehamwood United Kingdom)在2项(5%)中使用,Acrobot(The Acrobot Co. Ltd.,London,United Kingdom)在1项研究(3%)中使用。
  • 最常用的假体是Restoris MCK(Stryker)。
  • 9项研究(24%)未报告所用假体。
  • 六年随访的汇总生存率为96%。

局限性

  • 文献中报告机器人辅助单髁膝关节置换术时对假体选择的描述很少。
  • 机器人辅助单髁膝关节置换术能否转化为中长期假体生存改善尚待观察。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Robotic-assisted unicompartmental knee arthroplasty (UKA) promises accurate implant placement with the potential of improved survival and functional outcomes. The aim of this study was to present the current evidence for robotic-assisted UKA and describe the outcome in terms of implant positioning, range of movement (ROM), function and survival, and the types of robot and implants that are currently used. MATERIALS AND METHODS: A search of PubMed and Medline was performed in October 2018 in line with the Preferred Reporting Items for Systematic Review and Meta-Analysis statement. Search terms included "robotic", "knee", and "surgery". The criteria for inclusion was any study describing the use of robotic UKA and reporting implant positioning, ROM, function, and survival for clinical, cadaveric, or dry bone studies. RESULTS: A total of 528 articles were initially identified from the databases and reference lists. Following full text screening, 38 studies that satisfied the inclusion criteria were included. In all, 20 studies reported on implant positioning, 18 on functional outcomes, 16 on survivorship, and six on ROM. The Mako (Stryker, Mahwah, New Jersey) robot was used in 32 studies (84%), the BlueBelt Navio (Blue Belt Technologies, Plymouth, Minnesota) in three (8%), the Sculptor RGA (Stanmore Implants, Borehamwood United Kingdom) in two (5%), and the Acrobot (The Acrobot Co. Ltd., London, United Kingdom) in one study (3%). The most commonly used implant was the Restoris MCK (Stryker). Nine studies (24%) did not report the implant that was used. The pooled survivorship at six years follow-up was 96%. However, when assessing survival according to implant design, survivorship of an inlay (all-polyethylene) tibial implant was 89%, whereas that of an onlay (metal-backed) implant was 97% at six years (odds ratio 3.66, 95% confidence interval 20.7 to 6.46, p < 0.001). CONCLUSION: There is little description of the choice of implant when reporting robotic-assisted UKA, which is essential when assessing survivorship, in the literature. Implant positioning with robotic-assisted UKA is more accurate and more reproducible than that performed manually and may offer better functional outcomes, but whether this translates into improved implant survival in the mid- to longer-term remains to be seen. Cite this article: Bone Joint J 2019;101-B:838-847.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Robinson PG, Clement ND, Hamilton D, et al. A systematic review of robotic-assisted unicompartmental knee arthroplasty: prosthesis design and type should be reported. Bone Joint J. 2019. PMID: 31256672. doi:10.1302/0301-620X.101B7.BJJ-2018-1317.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。